← 產業報告目錄
Methotrexate Industry Research Report 2026
出版商 APO Research產業別 Healthcare & Life Sciences出版日期 2026-01-08頁數 115報告編號 APO-2a8b449281
授權報價
| Single User | $2,950 USD |
| Multi User | $4,430 USD |
| Enterprise | $5,900 USD |
報告摘要
Methotrexate is kwon as Amethopterin, Methotrexate Sodium, and MTX. It is a yellow or orange, crystalline powder, and made into methotrexate tablets and methotrexate for injection.
Methotrexate is used to treat certain types of cancer or to control severe psoriasis or rheumatoid arthritis. It may also be used to control juvenile rheumatoid arthritis.
North America is the largest Methotrexate market with about 49% market share. China is follower, accounting for about 12% market share.
The key players are Teva Pharmaceutical Industries, Qualitestrx(DAVA Pharmaceuticals), Pfizer (Hospira), Roxane Laboratories, Sine, Maoxiang, LingNan Pharmaceutical, Powerdone, Huiyu etc. Top 3 companies occupied about 65% market share.
Report Scope
This report quantifies the global Methotrexate market in terms of revenue (US$ million) and, where applicable, sales volume (Kg), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/Kg) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Methotrexate Market by Company
Teva Pharmaceutical Industries
Qualitestrx (DAVA Pharmaceuticals)
Pfizer (Hospira)
Roxane Laboratories
Sine
Maoxiang
LingNan Pharmaceutical
Powerdone
Huiyu
Methotrexate Segment by Type
Methotrexate for Injection
Methotrexate Tablets
Methotrexate Segment by Application
Used for Cancers
Used for Rheumatoid Arthritis
Used for Other Diseases
Methotrexate Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Methotrexate market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Methotrexate and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Methotrexate.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Methotrexate manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Methotrexate by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Methotrexate in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
目錄 Table of Contents
1 Preface
1.1 Scope of Report
1.2 Reasons for Doing This Study
1.3 Research Methodology
1.4 Research Process
1.5 Data Source
1.5.1 Secondary Sources
1.5.2 Primary Sources
2 Market Overview
2.1 Product Definition
2.2 Global Market Growth Prospects
2.2.1 Global Methotrexate Market Size (2021-2032)
2.2.2 Global Methotrexate Sales (2021-2032)
2.2.3 Global Methotrexate Market Average Price (2021-2032)
2.3 Methotrexate by Type
2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
2.3.2 Methotrexate for Injection
2.3.3 Methotrexate Tablets
2.4 Methotrexate by Application
2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
2.4.2 Used for Cancers
2.4.3 Used for Rheumatoid Arthritis
2.4.4 Used for Other Diseases
3 Market Competitive Landscape by Manufacturers
3.1 Global Methotrexate Market Competitive Situation by Manufacturers (2021 Versus 2025)
3.2 Global Methotrexate Sales (Kg) of Manufacturers (2021-2026)
3.3 Global Methotrexate Revenue of Manufacturers (2021-2026)
3.4 Global Methotrexate Average Price by Manufacturers (2021-2026)
3.5 Global Methotrexate Industry Ranking, 2024 VS 2025 VS 2026
3.6 Global Manufacturers of Methotrexate, Manufacturing Sites & Headquarters
3.7 Global Manufacturers of Methotrexate, Product Type & Application
3.8 Global Manufacturers of Methotrexate, Established Date
3.9 Global Methotrexate Market CR5 and HHI
3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
4.1 Teva Pharmaceutical Industries
4.1.1 Teva Pharmaceutical Industries Company Information
4.1.2 Teva Pharmaceutical Industries Business Overview
4.1.3 Teva Pharmaceutical Industries Methotrexate Sales, Revenue and Gross Margin (2021-2026)
4.1.4 Teva Pharmaceutical Industries Methotrexate Product Portfolio
4.1.5 Teva Pharmaceutical Industries Recent Developments
4.2 Qualitestrx (DAVA Pharmaceuticals)
4.2.1 Qualitestrx (DAVA Pharmaceuticals) Company Information
4.2.2 Qualitestrx (DAVA Pharmaceuticals) Business Overview
4.2.3 Qualitestrx (DAVA Pharmaceuticals) Methotrexate Sales, Revenue and Gross Margin (2021-2026)
4.2.4 Qualitestrx (DAVA Pharmaceuticals) Methotrexate Product Portfolio
4.2.5 Qualitestrx (DAVA Pharmaceuticals) Recent Developments
4.3 Pfizer (Hospira)
4.3.1 Pfizer (Hospira) Company Information
4.3.2 Pfizer (Hospira) Business Overview
4.3.3 Pfizer (Hospira) Methotrexate Sales, Revenue and Gross Margin (2021-2026)
4.3.4 Pfizer (Hospira) Methotrexate Product Portfolio
4.3.5 Pfizer (Hospira) Recent Developments
4.4 Roxane Laboratories
4.4.1 Roxane Laboratories Company Information
4.4.2 Roxane Laboratories Business Overview
4.4.3 Roxane Laboratories Methotrexate Sales, Revenue and Gross Margin (2021-2026)
4.4.4 Roxane Laboratories Methotrexate Product Portfolio
4.4.5 Roxane Laboratories Recent Developments
4.5 Sine
4.5.1 Sine Company Information
4.5.2 Sine Business Overview
4.5.3 Sine Methotrexate Sales, Revenue and Gross Margin (2021-2026)
4.5.4 Sine Methotrexate Product Portfolio
4.5.5 Sine Recent Developments
4.6 Maoxiang
4.6.1 Maoxiang Company Information
4.6.2 Maoxiang Business Overview
4.6.3 Maoxiang Methotrexate Sales, Revenue and Gross Margin (2021-2026)
4.6.4 Maoxiang Methotrexate Product Portfolio
4.6.5 Maoxiang Recent Developments
4.7 LingNan Pharmaceutical
4.7.1 LingNan Pharmaceutical Company Information
4.7.2 LingNan Pharmaceutical Business Overview
4.7.3 LingNan Pharmaceutical Methotrexate Sales, Revenue and Gross Margin (2021-2026)
4.7.4 LingNan Pharmaceutical Methotrexate Product Portfolio
4.7.5 LingNan Pharmaceutical Recent Developments
4.8 Powerdone
4.8.1 Powerdone Company Information
4.8.2 Powerdone Business Overview
4.8.3 Powerdone Methotrexate Sales, Revenue and Gross Margin (2021-2026)
4.8.4 Powerdone Methotrexate Product Portfolio
4.8.5 Powerdone Recent Developments
4.9 Huiyu
4.9.1 Huiyu Company Information
4.9.2 Huiyu Business Overview
4.9.3 Huiyu Methotrexate Sales, Revenue and Gross Margin (2021-2026)
4.9.4 Huiyu Methotrexate Product Portfolio
4.9.5 Huiyu Recent Developments
5 Global Methotrexate Market Scenario by Region
5.1 Global Methotrexate Market Size by Region: 2021 VS 2025 VS 2032
5.2 Global Methotrexate Sales by Region: 2021-2032
5.2.1 Global Methotrexate Sales by Region: 2021-2026
5.2.2 Global Methotrexate Sales by Region: 2027-2032
5.3 Global Methotrexate Revenue by Region: 2021-2032
5.3.1 Global Methotrexate Revenue by Region: 2021-2026
5.3.2 Global Methotrexate Revenue by Region: 2027-2032
5.4 North America Methotrexate Market Facts & Figures by Country
5.4.1 North America Methotrexate Market Size by Country: 2021 VS 2025 VS 2032
5.4.2 North America Methotrexate Sales by Country (2021-2032)
5.4.3 North America Methotrexate Revenue by Country (2021-2032)
5.4.4 United States
5.4.5 Canada
5.4.6 Mexico
5.5 Europe Methotrexate Market Facts & Figures by Country
5.5.1 Europe Methotrexate Market Size by Country: 2021 VS 2025 VS 2032
5.5.2 Europe Methotrexate Sales by Country (2021-2032)
5.5.3 Europe Methotrexate Revenue by Country (2021-2032)
5.5.4 Germany
5.5.5 France
5.5.6 U.K.
5.5.7 Italy
5.5.8 Russia
5.5.9 Spain
5.5.10 Netherlands
5.5.11 Switzerland
5.5.12 Sweden
5.5.13 Poland
5.6 Asia Pacific Methotrexate Market Facts & Figures by Country
5.6.1 Asia Pacific Methotrexate Market Size by Country: 2021 VS 2025 VS 2032
5.6.2 Asia Pacific Methotrexate Sales by Country (2021-2032)
5.6.3 Asia Pacific Methotrexate Revenue by Country (2021-2032)
5.6.4 China
5.6.5 Japan
5.6.6 South Korea
5.6.7 India
5.6.8 Australia
5.6.9 Taiwan
5.6.10 Southeast Asia
5.7 South America Methotrexate Market Facts & Figures by Country
5.7.1 South America Methotrexate Market Size by Country: 2021 VS 2025 VS 2032
5.7.2 South America Methotrexate Sales by Country (2021-2032)
5.7.3 South America Methotrexate Revenue by Country (2021-2032)
5.7.4 Brazil
5.7.5 Argentina
5.7.6 Chile
5.8 Middle East and Africa Methotrexate Market Facts & Figures by Country
5.8.1 Middle East and Africa Methotrexate Market Size by Country: 2021 VS 2025 VS 2032
5.8.2 Middle East and Africa Methotrexate Sales by Country (2021-2032)
5.8.3 Middle East and Africa Methotrexate Revenue by Country (2021-2032)
5.8.4 Egypt
5.8.5 South Africa
5.8.6 Israel
5.8.7 Türkiye
5.8.8 GCC Countries
6 Segment by Type
6.1 Global Methotrexate Sales by Type (2021-2032)
6.1.1 Global Methotrexate Sales by Type (2021-2032) & (Kg)
6.1.2 Global Methotrexate Sales Market Share by Type (2021-2032)
6.2 Global Methotrexate Revenue by Type (2021-2032)
6.2.1 Global Methotrexate Sales by Type (2021-2032) & (US$ Million)
6.2.2 Global Methotrexate Revenue Market Share by Type (2021-2032)
6.3 Global Methotrexate Price by Type (2021-2032)
7 Segment by Application
7.1 Global Methotrexate Sales by Application (2021-2032)
7.1.1 Global Methotrexate Sales by Application (2021-2032) & (Kg)
7.1.2 Global Methotrexate Sales Market Share by Application (2021-2032)
7.2 Global Methotrexate Revenue by Application (2021-2032)
7.2.1 Global Methotrexate Sales by Application (2021-2032) & (US$ Million)
7.2.2 Global Methotrexate Revenue Market Share by Application (2021-2032)
7.3 Global Methotrexate Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
8.1 Methotrexate Value Chain Analysis
8.1.1 Methotrexate Key Raw Materials
8.1.2 Raw Materials Key Suppliers
8.1.3 Methotrexate Production Mode & Process
8.2 Methotrexate Sales Channels Analysis
8.2.1 Direct Comparison with Distribution Share
8.2.2 Methotrexate Distributors
8.2.3 Methotrexate Customers
9 Global Methotrexate Analyzing Market Dynamics
9.1 Methotrexate Industry Trends
9.2 Methotrexate Industry Drivers
9.3 Methotrexate Industry Opportunities and Challenges
9.4 Methotrexate Industry Restraints
10 Report Conclusion
11 Disclaimer
圖表清單 List of Tables & Figures
List of Tables
Table 1. Secondary Sources
Table 2. Primary Sources
Table 3. Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
Table 4. Market Value Comparison by Application (2021 VS 2025 VS 2032) & (US$ Million)
Table 5. Global Methotrexate Volume and Revenue Market Size and CAGR of Manufacturers (2021 Versus 2025)
Table 6. Global Methotrexate Sales (Kg) of Manufacturers (2021-2026)
Table 7. Global Methotrexate Sales Market Share by Manufacturers (2021-2026)
Table 8. Global Methotrexate Revenue of Manufacturers (2021-2026)
Table 9. Global Methotrexate Revenue Share by Manufacturers (2021-2026)
Table 10. Global Market Methotrexate Average Price (USD/Kg) of Manufacturers (2021-2026)
Table 11. Global Methotrexate Industry Ranking, 2024 VS 2025 VS 2026
Table 12. Global Manufacturers of Methotrexate, Manufacturing Sites & Headquarters
Table 13. Global Manufacturers of Methotrexate, Product Type & Application
Table 14. Global Methotrexate Manufacturers Established Date
Table 15. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 16. Global Methotrexate by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025)
Table 17. Manufacturers Mergers & Acquisitions, Expansion Plans)
Table 18. Teva Pharmaceutical Industries Company Information
Table 19. Teva Pharmaceutical Industries Business Overview
Table 20. Teva Pharmaceutical Industries Methotrexate Sales (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2021-2026)
Table 21. Teva Pharmaceutical Industries Methotrexate Product Portfolio
Table 22. Teva Pharmaceutical Industries Recent Developments
Table 23. Qualitestrx (DAVA Pharmaceuticals) Company Information
Table 24. Qualitestrx (DAVA Pharmaceuticals) Business Overview
Table 25. Qualitestrx (DAVA Pharmaceuticals) Methotrexate Sales (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2021-2026)
Table 26. Qualitestrx (DAVA Pharmaceuticals) Methotrexate Product Portfolio
Table 27. Qualitestrx (DAVA Pharmaceuticals) Recent Developments
Table 28. Pfizer (Hospira) Company Information
Table 29. Pfizer (Hospira) Business Overview
Table 30. Pfizer (Hospira) Methotrexate Sales (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2021-2026)
Table 31. Pfizer (Hospira) Methotrexate Product Portfolio
Table 32. Pfizer (Hospira) Recent Developments
Table 33. Roxane Laboratories Company Information
Table 34. Roxane Laboratories Business Overview
Table 35. Roxane Laboratories Methotrexate Sales (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2021-2026)
Table 36. Roxane Laboratories Methotrexate Product Portfolio
Table 37. Roxane Laboratories Recent Developments
Table 38. Sine Company Information
Table 39. Sine Business Overview
Table 40. Sine Methotrexate Sales (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2021-2026)
Table 41. Sine Methotrexate Product Portfolio
Table 42. Sine Recent Developments
Table 43. Maoxiang Company Information
Table 44. Maoxiang Business Overview
Table 45. Maoxiang Methotrexate Sales (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2021-2026)
Table 46. Maoxiang Methotrexate Product Portfolio
Table 47. Maoxiang Recent Developments
Table 48. LingNan Pharmaceutical Company Information
Table 49. LingNan Pharmaceutical Business Overview
Table 50. LingNan Pharmaceutical Methotrexate Sales (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2021-2026)
Table 51. LingNan Pharmaceutical Methotrexate Product Portfolio
Table 52. LingNan Pharmaceutical Recent Developments
Table 53. Powerdone Company Information
Table 54. Powerdone Business Overview
Table 55. Powerdone Methotrexate Sales (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2021-2026)
Table 56. Powerdone Methotrexate Product Portfolio
Table 57. Powerdone Recent Developments
Table 58. Huiyu Company Information
Table 59. Huiyu Business Overview
Table 60. Huiyu Methotrexate Sales (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2021-2026)
Table 61. Huiyu Methotrexate Product Portfolio
Table 62. Huiyu Recent Developments
Table 63. Global Methotrexate Market Size by Region (US$ Million): 2021 VS 2025 VS 2032
Table 64. Global Methotrexate Sales by Region (2021-2026) & (Kg)
Table 65. Global Methotrexate Sales Market Share by Region (2021-2026)
Table 66. Global Methotrexate Sales by Region (2027-2032) & (Kg)
Table 67. Global Methotrexate Sales Market Share by Region (2027-2032)
Table 68. Global Methotrexate Revenue by Region (2021-2026) & (US$ Million)
Table 69. Global Methotrexate Revenue Market Share by Region (2021-2026)
Table 70. Global Methotrexate Revenue by Region (2027-2032) & (US$ Million)
Table 71. Global Methotrexate Revenue Market Share by Region (2027-2032)
Table 72. North America Methotrexate Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million)
Table 73. North America Methotrexate Sales by Country (2021-2026) & (Kg)
Table 74. North America Methotrexate Sales by Country (2027-2032) & (Kg)
Table 75. North America Methotrexate Revenue by Country (2021-2026) & (US$ Million)
Table 76. North America Methotrexate Revenue by Country (2027-2032) & (US$ Million)
Table 77. Europe Methotrexate Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million)
Table 78. Europe Methotrexate Sales by Country (2021-2026) & (Kg)
Table 79. Europe Methotrexate Sales by Country (2027-2032) & (Kg)
Table 80. Europe Methotrexate Revenue by Country (2021-2026) & (US$ Million)
Table 81. Europe Methotrexate Revenue by Country (2027-2032) & (US$ Million)
Table 82. Asia Pacific Methotrexate Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million)
Table 83. Asia Pacific Methotrexate Sales by Country (2021-2026) & (Kg)
Table 84. Asia Pacific Methotrexate Sales by Country (2027-2032) & (Kg)
Table 85. Asia Pacific Methotrexate Revenue by Country (2021-2026) & (US$ Million)
Table 86. Asia Pacific Methotrexate Revenue by Country (2027-2032) & (US$ Million)
Table 87. South America Methotrexate Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million)
Table 88. South America Methotrexate Sales by Country (2021-2026) & (Kg)
Table 89. South America Methotrexate Sales by Country (2027-2032) & (Kg)
Table 90. South America Methotrexate Revenue by Country (2021-2026) & (US$ Million)
Table 91. South America Methotrexate Revenue by Country (2027-2032) & (US$ Million)
Table 92. Middle East and Africa Methotrexate Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million)
Table 93. Middle East and Africa Methotrexate Sales by Country (2021-2026) & (Kg)
Table 94. Middle East and Africa Methotrexate Sales by Country (2027-2032) & (Kg)
Table 95. Middle East and Africa Methotrexate Revenue by Country (2021-2026) & (US$ Million)
Table 96. Middle East and Africa Methotrexate Revenue by Country (2027-2032) & (US$ Million)
Table 97. Global Methotrexate Sales by Type (2021-2026) & (Kg)
Table 98. Global Methotrexate Sales by Type (2027-2032) & (Kg)
Table 99. Global Methotrexate Sales Market Share by Type (2021-2026)
Table 100. Global Methotrexate Sales Market Share by Type (2027-2032)
Table 101. Global Methotrexate Revenue by Type (2021-2026) & (US$ Million)
Table 102. Global Methotrexate Revenue by Type (2027-2032) & (US$ Million)
Table 103. Global Methotrexate Revenue Market Share by Type (2021-2026)
Table 104. Global Methotrexate Revenue Market Share by Type (2027-2032)
Table 105. Global Methotrexate Price by Type (2021-2026) & (USD/Kg)
Table 106. Global Methotrexate Price by Type (2027-2032) & (USD/Kg)
Table 107. Global Methotrexate Sales by Application (2021-2026) & (Kg)
Table 108. Global Methotrexate Sales by Application (2027-2032) & (Kg)
Table 109. Global Methotrexate Sales Market Share by Application (2021-2026)
Table 110. Global Methotrexate Sales Market Share by Application (2027-2032)
Table 111. Global Methotrexate Revenue by Application (2021-2026) & (US$ Million)
Table 112. Global Methotrexate Revenue by Application (2027-2032) & (US$ Million)
Table 113. Global Methotrexate Revenue Market Share by Application (2021-2026)
Table 114. Global Methotrexate Revenue Market Share by Application (2027-2032)
Table 115. Global Methotrexate Price by Application (2021-2026) & (USD/Kg)
Table 116. Global Methotrexate Price by Application (2027-2032) & (USD/Kg)
Table 117. Key Raw Materials
Table 118. Raw Materials Key Suppliers
Table 119. Methotrexate Distributors List
Table 120. Methotrexate Customers List
Table 121. Methotrexate Industry Trends
Table 122. Methotrexate Industry Drivers
Table 123. Methotrexate Industry Restraints
Table 124. Authors List of This Report
List of Figures
Figure 1. Research Methodology
Figure 2. Research Process
Figure 3. Key Executives Interviewed
Figure 4. Methotrexate Product Image
Figure 5. Global Methotrexate Revenue (US$ Million), 2021 VS 2025 VS 2032
Figure 6. Global Methotrexate Market Size (2021-2032) & (US$ Million)
Figure 7. Global Methotrexate Sales (2021-2032) & (Kg)
Figure 8. Global Methotrexate Average Price (USD/Kg) & (2021-2032)
Figure 9. Methotrexate for Injection Product Image
Figure 10. Methotrexate Tablets Product Image
Figure 11. Used for Cancers Product Image
Figure 12. Used for Rheumatoid Arthritis Product Image
Figure 13. Used for Other Diseases Product Image
Figure 14. Global Methotrexate Revenue Share by Manufacturers in 2025
Figure 15. Global Manufacturers of Methotrexate, Manufacturing Sites & Headquarters
Figure 16. Global Top 5 and 10 Methotrexate Players Market Share by Revenue in 2025
Figure 17. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025
Figure 18. Global Methotrexate Market Size by Region (US$ Million): 2021 VS 2025 VS 2032
Figure 19. Global Methotrexate Sales by Region in 2025
Figure 20. Global Methotrexate Revenue by Region in 2025
Figure 21. North America Methotrexate Market Size by Country in 2025
Figure 22. North America Methotrexate Sales Market Share by Country (2021-2032)
Figure 23. North America Methotrexate Revenue Market Share by Country (2021-2032)
Figure 24. United States Methotrexate Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 25. Canada Methotrexate Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 26. Mexico Methotrexate Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 27. Europe Methotrexate Market Size by Country in 2025
Figure 28. Europe Methotrexate Sales Market Share by Country (2021-2032)
Figure 29. Europe Methotrexate Revenue Market Share by Country (2021-2032)
Figure 30. Germany Methotrexate Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 31. France Methotrexate Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 32. U.K. Methotrexate Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 33. Italy Methotrexate Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 34. Russia Methotrexate Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 35. Spain Methotrexate Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 36. Netherlands Methotrexate Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 37. Switzerland Methotrexate Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 38. Sweden Methotrexate Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 39. Poland Methotrexate Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 40. Asia Pacific Methotrexate Market Size by Country in 2025
Figure 41. Asia Pacific Methotrexate Sales Market Share by Country (2021-2032)
Figure 42. Asia Pacific Methotrexate Revenue Market Share by Country (2021-2032)
Figure 43. China Methotrexate Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 44. Japan Methotrexate Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 45. South Korea Methotrexate Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 46. India Methotrexate Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 47. Australia Methotrexate Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 48. Taiwan Methotrexate Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 49. Southeast Asia Methotrexate Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 50. Southeast Asia Methotrexate Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 51. South America Methotrexate Market Size by Country in 2025
Figure 52. South America Methotrexate Sales Market Share by Country (2021-2032)
Figure 53. South America Methotrexate Revenue Market Share by Country (2021-2032)
Figure 54. Brazil Methotrexate Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 55. Argentina Methotrexate Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 56. Chile Methotrexate Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 57. Middle East and Africa Methotrexate Market Size by Country in 2025
Figure 58. Middle East and Africa Methotrexate Sales Market Share by Country (2021-2032)
Figure 59. Middle East and Africa Methotrexate Revenue Market Share by Country (2021-2032)
Figure 60. Egypt Methotrexate Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 61. South Africa Methotrexate Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 62. Israel Methotrexate Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 63. Türkiye Methotrexate Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 64. GCC Countries Methotrexate Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 65. Global Methotrexate Sales Market Share by Type (2021-2032)
Figure 66. Global Methotrexate Revenue Market Share by Type (2021-2032)
Figure 67. Global Methotrexate Price (USD/Kg) by Type (2021-2032)
Figure 68. Global Methotrexate Sales Market Share by Application (2021-2032)
Figure 69. Global Methotrexate Revenue Market Share by Application (2021-2032)
Figure 70. Global Methotrexate Price (USD/Kg) by Application (2021-2032)
Figure 71. Methotrexate Value Chain
Figure 72. Methotrexate Production Mode & Process
Figure 73. Direct Comparison with Distribution Share
Figure 74. Distributors Profiles
Figure 75. Methotrexate Industry Opportunities and Challenges
提及公司
Teva Pharmaceutical IndustriesQualitestrx (DAVA Pharmaceuticals)Pfizer (Hospira)Roxane LaboratoriesSineMaoxiangLingNan PharmaceuticalPowerdoneHuiyu
量子訊息有限公司為 APO Research 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們